Search
forLearn
5 / 801 resultslearn octapeptide-2
learn glutamic acid
learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
learn madecassoside
Research
5 / 661 results
research Skin manifestations amongGATA2-deficient patients
Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.
research The function of TRPS1 in the development and differentiation of bone, kidney, and hair follicles.
TRPS1 is crucial for bone, kidney, and hair follicle development.
research Decreased GATA3 levels cause changed mouse cutaneous innate lymphoid cell fate, facilitating hair follicle recycling
Lower GATA3 levels in mice help hair regrow by changing certain immune cells.
research Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment
TACE/ADAM17 is essential for maintaining healthy hair and hair follicle stem cells.
research The Correlations of Vitamin D and Zinc Deficiency with Neck Pain, Fatigue, and Tremors of Muscle: A Case Report and Review of Article
Vitamin D and Zinc deficiencies can cause various symptoms, but supplements and lifestyle changes can improve them.
Community Join
5 / 1000+ resultscommunity This is an 8 week difference. Is this progress of any sort?
The user experienced significant hair regrowth over 8 weeks using oral Minoxidil and Dutasteride, noting healthier and denser hair. They reported no side effects and emphasized the importance of staying consistent with the treatment despite initial shedding.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Anagenic is trying to compound Gt20029
The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.
community What is preventing GT20029 from being the cure to androgenetic hair loss?
GT20029 is discussed as a potential treatment for androgenetic hair loss by targeting androgen receptors, unlike finasteride which reduces DHT broadly. Concerns include its effectiveness, genetic variations in androgen receptors, and availability, with some skepticism about its potential as a true alternative.
community Where is GT20029 already? Grrrr
The conversation is about frustration over the delay in phase 2 results for a hair loss treatment called GT20029. One user suspects the treatment may have failed.